Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$2.17B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.82B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$1.37B |
| 4 |
Linde
LIN
|
+$756M |
| 5 |
DuPont de Nemours
DD
|
+$595M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$1.51B |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$315M |
| 3 |
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
|
+$314M |
| 4 |
Microsoft
MSFT
|
+$264M |
| 5 |
PPLI
People Inc
PPLI
|
+$239M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.07% |
| 2 | Financials | 6.12% |
| 3 | Healthcare | 5.17% |
| 4 | Consumer Discretionary | 4.88% |
| 5 | Communication Services | 4.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3726
Scholar Rock
SRRK
$6.4B
| $222K | ﹤0.01% |
12,555
+23
| +0.2% | +$342 |
|
3727
VirnetX Holding Corp
VHC
$61.2M
| $222K | ﹤0.01% |
2,117
-266
| -11% | -$28.5K |
|
3728
CALL
Williams Companies
WMB
$91.6B
| $222K | ﹤0.01% |
11,300
| – | – |
|
|
GTHX
3729
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $222K | ﹤0.01% |
19,298
-4,606
| -19% | -$76K |
|
|
BCLI
3730
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
| $221K | ﹤0.01% |
872
-106
| -11% | -$21.7K |
|
3731
PUT
CarMax
KMX
$8.47B
| $221K | ﹤0.01% |
2,400
-1,300
| -35% | -$130K |
|
|
MESO
3732
Mesoblast
MESO
$2.02B
| $221K | ﹤0.01% |
5,950
+5,500
| +1,222% | +$172K |
|
|
FONR
3733
DELISTED
Fonar
FONR
| $220K | ﹤0.01% |
10,512
-2,968
| -22% | -$71.5K |
|
3734
CALL
Perrigo
PRGO
$1.77B
| $220K | ﹤0.01% |
4,800
-27,600
| -85% | -$1.45M |
|
3735
Replimune Group
REPL
$1.41B
| $220K | ﹤0.01% |
9,550
-1,401
| -13% | -$31.9K |
|
3736
CALL
Cheesecake Factory
CAKE
$5.59B
| $219K | ﹤0.01% |
7,900
| – | – |
|
3737
PUT
iShares US Transportation ETF
IYT
$2.29B
| $219K | ﹤0.01% |
4,400
| – | – |
|
3738
BRC Group Holdings
RILY
$297M
| $219K | ﹤0.01% |
8,731
-2,347
| -21% | -$59K |
|
3739
KALA BIO
KALA
$17.6M
| $218K | ﹤0.01% |
12
-52
| -81% | -$1.2M |
|
|
CBL
3740
DELISTED
CBL& Associates Properties, Inc.
CBL
| $218K | ﹤0.01% |
1,355,606
+1,349,384
| +21,687% | +$275K |
|
3741
Sterling Infrastructure
STRL
$17.5B
| $217K | ﹤0.01% |
15,313
-2,523
| -14% | -$31.7K |
|
|
KSU
3742
PUT
DELISTED
Kansas City Southern
KSU
| $217K | ﹤0.01% |
1,200
-57,400
| -98% | -$9.94M |
|
3743
iRadimed
IRMD
$1.1B
| $216K | ﹤0.01% |
10,169
-2,753
| -21% | -$61.8K |
|
3744
Origin Bancorp
OBK
$1.68B
| $216K | ﹤0.01% |
10,071
-2,004
| -17% | -$44.9K |
|
3745
SM Energy
SM
$8.04B
| $216K | ﹤0.01% |
136,008
-89,923
| -40% | -$251K |
|
3746
Prothena Corp
PRTA
$463M
| $215K | ﹤0.01% |
21,409
-6,757
| -24% | -$81.3K |
|
|
AKTS
3747
DELISTED
Akoustis Technologies Inc
AKTS
| $215K | ﹤0.01% |
26,377
-2,830
| -10% | -$22.9K |
|
3748
PUT
Bausch Health
BHC
$2.42B
| $214K | ﹤0.01% |
13,800
-6,500
| -32% | -$112K |
|
3749
Pembina Pipeline
PBA
$28.7B
| $214K | ﹤0.01% |
10,033
-3,823
| -28% | -$93.9K |
|
3750
Ceco Environmental
CECO
$4.56B
| $213K | ﹤0.01% |
29,274
-5,309
| -15% | -$40.1K |
|
Similar funds
Barclays's Q3 2020 Portfolio in Review
As of Q3 2020, Barclays held 5,906 positions worth $168B, up 30% from $129B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Barclays deployed $26.3B of net new capital in Q3 2020, opening 241 new positions and adding to 1,886 existing holdings. Its largest new stake was State Street SPDR Bloomberg High Yield Bond ETF: 771,265 shares worth $80.4M.
By sector, the portfolio is most concentrated in Technology at 9.1% of assets, down from 9.9% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $1.51B trimmed.
- Barclays's largest Q3 2020 buy was State Street SPDR Bloomberg High Yield Bond ETF: 771,265 shares worth $80.4M.
- Barclays added most to Visa in Q3 2020, an estimated $2.17B increase.
- Barclays's biggest Q3 2020 reduction was iShares iBoxx $ High Yield Corporate Bond ETF, cutting an estimated $1.51B.
- Barclays fully exited People Inc in Q3 2020, selling an estimated $239M.
- Barclays's ten largest holdings make up 34% of its $168B portfolio in Q3 2020.
- Barclays opened 241 new positions and closed 676 in Q3 2020.
- Barclays's portfolio value rose 30% quarter-over-quarter to $168B.
Based on Barclays's 13F filing for Q3 2020, filed 12 Nov 2020.